Cargando…
Reduction of Cardiac Autonomic Modulation and Increased Sympathetic Activity by Heart Rate Variability in Patients With Long COVID
Although several clinical manifestations of persistent long coronavirus disease (COVID-19) have been documented, their effects on the cardiovascular and autonomic nervous system over the long term remain unclear. Thus, we examined the presence of alterations in cardiac autonomic functioning in indiv...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098798/ https://www.ncbi.nlm.nih.gov/pubmed/35571200 http://dx.doi.org/10.3389/fcvm.2022.862001 |
_version_ | 1784706457863716864 |
---|---|
author | Marques, Karina Carvalho Silva, Camilla Costa Trindade, Steffany da Silva Santos, Márcio Clementino de Souza Rocha, Rodrigo Santiago Barbosa Vasconcelos, Pedro Fernando da Costa Quaresma, Juarez Antônio Simões Falcão, Luiz Fábio Magno |
author_facet | Marques, Karina Carvalho Silva, Camilla Costa Trindade, Steffany da Silva Santos, Márcio Clementino de Souza Rocha, Rodrigo Santiago Barbosa Vasconcelos, Pedro Fernando da Costa Quaresma, Juarez Antônio Simões Falcão, Luiz Fábio Magno |
author_sort | Marques, Karina Carvalho |
collection | PubMed |
description | Although several clinical manifestations of persistent long coronavirus disease (COVID-19) have been documented, their effects on the cardiovascular and autonomic nervous system over the long term remain unclear. Thus, we examined the presence of alterations in cardiac autonomic functioning in individuals with long-term manifestations. The study was conducted from October 2020 to May 2021, and an autonomic assessment was performed to collect heart rate data for the heart rate variability (HRV) analysis. The study participants were divided into the long COVID clinical group, the intragroup, which included patients who were hospitalized, and those who were not hospitalized and were symptomatic for different periods (≤3, >3, ≤6, and >6 months), with and without dyspnoea. The control group, the intergroup, comprised of COVID-free individuals. Our results demonstrated that the long COVID clinical group showed reduced HRV compared with the COVID-19-uninfected control group. Patients aged 23–59 years developed COVID symptoms within 30 days after infection, whose diagnosis was confirmed by serologic or reverse-transcription polymerase chain reaction (swab) tests, were included in the study. A total of 155 patients with long COVID [95 women (61.29%), mean age 43.88 ± 10.88 years and 60 men (38.71%), mean age 43.93 ± 10.11 years] and 94 controls [61 women (64.89%), mean age 40.83 ± 6.31 and 33 men (35.11%), mean age 40.69 ± 6.35 years] were included. The intragroup and intergroup comparisons revealed a reduction in global HRV, increased sympathetic modulation influence, and a decrease in parasympathetic modulation in long COVID. The intragroup showed normal sympathovagal balance, while the intergroup showed reduced sympathovagal balance. Our findings indicate that long COVID leads to sympathetic excitation influence and parasympathetic reduction. The excitation can increase the heart rate and blood pressure and predispose to cardiovascular complications. Short-term HRV analysis showed good reproducibility to verify the cardiac autonomic involvement. |
format | Online Article Text |
id | pubmed-9098798 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90987982022-05-14 Reduction of Cardiac Autonomic Modulation and Increased Sympathetic Activity by Heart Rate Variability in Patients With Long COVID Marques, Karina Carvalho Silva, Camilla Costa Trindade, Steffany da Silva Santos, Márcio Clementino de Souza Rocha, Rodrigo Santiago Barbosa Vasconcelos, Pedro Fernando da Costa Quaresma, Juarez Antônio Simões Falcão, Luiz Fábio Magno Front Cardiovasc Med Cardiovascular Medicine Although several clinical manifestations of persistent long coronavirus disease (COVID-19) have been documented, their effects on the cardiovascular and autonomic nervous system over the long term remain unclear. Thus, we examined the presence of alterations in cardiac autonomic functioning in individuals with long-term manifestations. The study was conducted from October 2020 to May 2021, and an autonomic assessment was performed to collect heart rate data for the heart rate variability (HRV) analysis. The study participants were divided into the long COVID clinical group, the intragroup, which included patients who were hospitalized, and those who were not hospitalized and were symptomatic for different periods (≤3, >3, ≤6, and >6 months), with and without dyspnoea. The control group, the intergroup, comprised of COVID-free individuals. Our results demonstrated that the long COVID clinical group showed reduced HRV compared with the COVID-19-uninfected control group. Patients aged 23–59 years developed COVID symptoms within 30 days after infection, whose diagnosis was confirmed by serologic or reverse-transcription polymerase chain reaction (swab) tests, were included in the study. A total of 155 patients with long COVID [95 women (61.29%), mean age 43.88 ± 10.88 years and 60 men (38.71%), mean age 43.93 ± 10.11 years] and 94 controls [61 women (64.89%), mean age 40.83 ± 6.31 and 33 men (35.11%), mean age 40.69 ± 6.35 years] were included. The intragroup and intergroup comparisons revealed a reduction in global HRV, increased sympathetic modulation influence, and a decrease in parasympathetic modulation in long COVID. The intragroup showed normal sympathovagal balance, while the intergroup showed reduced sympathovagal balance. Our findings indicate that long COVID leads to sympathetic excitation influence and parasympathetic reduction. The excitation can increase the heart rate and blood pressure and predispose to cardiovascular complications. Short-term HRV analysis showed good reproducibility to verify the cardiac autonomic involvement. Frontiers Media S.A. 2022-04-29 /pmc/articles/PMC9098798/ /pubmed/35571200 http://dx.doi.org/10.3389/fcvm.2022.862001 Text en Copyright © 2022 Marques, Silva, Trindade, Santos, Rocha, Vasconcelos, Quaresma and Falcão. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Marques, Karina Carvalho Silva, Camilla Costa Trindade, Steffany da Silva Santos, Márcio Clementino de Souza Rocha, Rodrigo Santiago Barbosa Vasconcelos, Pedro Fernando da Costa Quaresma, Juarez Antônio Simões Falcão, Luiz Fábio Magno Reduction of Cardiac Autonomic Modulation and Increased Sympathetic Activity by Heart Rate Variability in Patients With Long COVID |
title | Reduction of Cardiac Autonomic Modulation and Increased Sympathetic Activity by Heart Rate Variability in Patients With Long COVID |
title_full | Reduction of Cardiac Autonomic Modulation and Increased Sympathetic Activity by Heart Rate Variability in Patients With Long COVID |
title_fullStr | Reduction of Cardiac Autonomic Modulation and Increased Sympathetic Activity by Heart Rate Variability in Patients With Long COVID |
title_full_unstemmed | Reduction of Cardiac Autonomic Modulation and Increased Sympathetic Activity by Heart Rate Variability in Patients With Long COVID |
title_short | Reduction of Cardiac Autonomic Modulation and Increased Sympathetic Activity by Heart Rate Variability in Patients With Long COVID |
title_sort | reduction of cardiac autonomic modulation and increased sympathetic activity by heart rate variability in patients with long covid |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098798/ https://www.ncbi.nlm.nih.gov/pubmed/35571200 http://dx.doi.org/10.3389/fcvm.2022.862001 |
work_keys_str_mv | AT marqueskarinacarvalho reductionofcardiacautonomicmodulationandincreasedsympatheticactivitybyheartratevariabilityinpatientswithlongcovid AT silvacamillacosta reductionofcardiacautonomicmodulationandincreasedsympatheticactivitybyheartratevariabilityinpatientswithlongcovid AT trindadesteffanydasilva reductionofcardiacautonomicmodulationandincreasedsympatheticactivitybyheartratevariabilityinpatientswithlongcovid AT santosmarcioclementinodesouza reductionofcardiacautonomicmodulationandincreasedsympatheticactivitybyheartratevariabilityinpatientswithlongcovid AT rocharodrigosantiagobarbosa reductionofcardiacautonomicmodulationandincreasedsympatheticactivitybyheartratevariabilityinpatientswithlongcovid AT vasconcelospedrofernandodacosta reductionofcardiacautonomicmodulationandincreasedsympatheticactivitybyheartratevariabilityinpatientswithlongcovid AT quaresmajuarezantoniosimoes reductionofcardiacautonomicmodulationandincreasedsympatheticactivitybyheartratevariabilityinpatientswithlongcovid AT falcaoluizfabiomagno reductionofcardiacautonomicmodulationandincreasedsympatheticactivitybyheartratevariabilityinpatientswithlongcovid |